Nafld Clinical Trials 2022

Browse 31 Nafld Medical Studies Across 108 Cities

2 Phase 3 Trial · 273 Nafld Clinics

Reviewed by Michael Gill, B. Sc.
Photo of university of alabama at birmingham 1
Phase-Based Progress Estimates
1
Effectiveness
1
Safety

Moderately Carbohydrate-restricted Dietfor Obesity

Birmingham, AL
< 18
All Sexes
This will be a 6-month randomized clinical trial with two arms: moderately carbohydrate-restricted diet and a fat-restricted control diet. This 6-month study will have 2 phases: a 12-week controlled feeding phase and a 12-week "free living" phase. During the controlled feeding phase, all food will be provided to the families of the participants for the entirety of the 12 weeks. Participants (n=80) will have been diagnosed with NAFLD based on the presence of current evidence of active disease, which will be determined by the ongoing presence of hepatic steatosis estimated by diffusely echogenic liver via ultrasound suggestive of fatty liver and a serum alanine aminotransferase (ALT) level of 45 U/L or greater. All participants will be children and adolescents age 12-17 yrs.; will have an HbA1c <7.0; and will be overweight or obese (BMI >85th percentile). It is anticipated that most participants will be sedentary. The investigators will inquire as to routine physical activity at screening. All participants will be asked to maintain their usual level of physical activity throughout the study. Physical activity will be monitored via a smart watch provided to each participant at the beginning of the study, and participants will be queried weekly by the study dietitian regarding changes in physical activity. Participants who use oral contraceptives will be asked to maintain consistent use of these preparations throughout the study. Hormone use will be examined as a potential covariate in statistical analyses.
Recruiting
Has No Placebo
Photo of montreal 1
Phase-Based Progress Estimates
1
Effectiveness
1
Safety

Omega 3for Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD

Montreal, Canada
< 65
Male
Nonalcoholic hepatic steatosis (NASH) is defined as the amount greater than 5% of the total liver volume fat. Commonly known as NASH, it includes 4 stages histological ranging from the mere presence of fat to the existence of fibrosis and degeneration of hepatocytes, and finally a progression to cirrhosis, sometimes accompanied by complications of hepatocellular carcinoma. It is a common condition associated with a combination of disorders, namely obesity, insulin resistance and type 2 diabetes. The link with the metabolic syndrome (MetS) was mainly studied in the adult population and very little in the paediatric population, while 15 and 25% of obese children are affectés. The severity of histological disease appears to be associated with the degree of obesity in children and particularly in the MetS. in addition, epidemiological data indicate that the incidence of this disease is increasing in children and positioning as the first NASH liver disease in North America. the revelation of the factors associated with the occurrence of NASH is a first necessary step to understanding this disorder worrying for the future of children and adolescents. In addition, clarification of the mechanisms responsible for its development is essential if the investigators want to consider targeted and effective treatments to slow the rat race of NASH, which stands out as the supreme chronic liver accompanying the obesity and MetS. Finally, in view of growth and puberty of children, it would be extremely beneficial to find nutritional avenues that would avoid the side effects of chemical agents.
Phase 1 & 2
Waitlist Available
25 Nafld Clinical Trials Near Me
San Antonio, TX
Edmonton, Canada
Montreal, Canada
Birmingham, AL
More Trial Locations
An interactive map to display trial locations for Texas Liver Institute, Clinical Research Unit, University of Alberta, McGill University Health Center, University of Alabama at Birmingham, and 146 more locations.
Most Popular References for Nafld Clinical Trials
Frequency
Citation
Top Hospitals for Nafld Clinical Trials
Location
Active Nafld Clinical Trials
All Time Trials for Nafld
First Recorded Nafld Trial
Trials
Catalina Research Institute, Montclair, California
4
11
2016
Top Cities for Nafld Clinical Trials
City
Active Nafld Clinical Trials
Top Active Site for Nafld Clinical Trials
Trial List
Chandler, Arizona
9
Arizona Liver Health - Chandler
Richmond, Virginia
8
National Clinical Research - Richmond
Phase 3 Nafld Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Recently Completed Studies with FDA Approved Treatments for Nafld
Treatment
Year
Mechanism of Action
Sponsor
Active Nafld Clinical Trials
BIO89-100
2021
89bio, Inc.
0
ORMD-0801 (Insulin) capsule 8 mg BD
2020
Insulin human
Oramed, Ltd.
0
PF-06865571
2020
Pfizer
0

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 13th, 2021

Last Reviewed: September 11th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.